Merck (MRK) Prices $8B Senior Unsecured Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/27/2024
- Wall Street shares close up as megacap tech stocks rally
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil settles higher on supply concerns in the Mideast, economic woes subdue gains
- 'This is Enron:' Facebook and Asana co-founder accuses Tesla of 'massive' fraud
- Vietnam delays launch of new stock trading system
- Biden appears in live interview with Howard Stern
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- Wall Street shares close up as megacap tech stocks rally
- Midday movers: Alphabet, Microsoft and Snap rise; Intel, Hertz Global fall
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
Merck Prices $8.0 Billion Debt Offering
December 7, 2021 7:18 PM ESTKENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today priced an $8.0 billion public offering of five series of senior unsecured notes (collectively, the notes). The notes include:
$1.5 billion of 1.700% notes due 2027 (the 2027 notes)
$1.0 billion of 1.900% notes due 2028 (the sustainability notes)
$2.0 billion of 2.150% notes due 2031 (the 2031 notes)
$2.0 billion of 2.750% notes due 2051 (the 2051 notes)
$1.5 billion of 2.900% notes due 2061 (the 2061 notes)
Merck intends to use the net proceeds from the offering of the 2027 notes, the 2031... More
